Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)–Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients
Michelle A. Barron(Colorado School of Public Health), Adriana Weinberg(University of Colorado Anschutz Medical Campus), Dexiang Gao(University of Colorado Cancer Center), Mark W. Brunvand(University of Washington), Anna E. Barón(Colorado School of Public Health), Julie A. Patterson(Northern Illinois University), Peter A. McSweeney(Mesoblast (United States)), Kathryn L. Springer(Infectious Disease Consultants)
Cited by 59
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k